141 related articles for article (PubMed ID: 12003409)
1. Treatment of Crohn's disease with budesonide: this rose still has thorns!
Valentine JF
Am J Gastroenterol; 2002 Apr; 97(4):785-6. PubMed ID: 12003409
[No Abstract] [Full Text] [Related]
2. Budesonide for Crohn's disease.
Seow CH; Benchimol EI; Steinhart AH; Griffiths AM; Otley AR
Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):971-9. PubMed ID: 19611401
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of controlled-release budesonide in preserving bone mineral density in patients with Crohn's disease.
Abreu MT
Nat Clin Pract Gastroenterol Hepatol; 2005 May; 2(5):210-1. PubMed ID: 16265201
[No Abstract] [Full Text] [Related]
4. Bone mineral density in Crohn's disease: a longitudinal study of budesonide, prednisone, and nonsteroid therapy.
Cino M; Greenberg GR
Am J Gastroenterol; 2002 Apr; 97(4):915-21. PubMed ID: 12003427
[TBL] [Abstract][Full Text] [Related]
5. Budesonide: its role in Crohn's disease therapy.
Coleman CI; Reddy P; White CM
Conn Med; 2002 Sep; 66(9):523-6. PubMed ID: 12369546
[No Abstract] [Full Text] [Related]
6. Reviewing the therapeutic role of budesonide in Crohn's disease.
López-Sanromán A; Clofent J; Garcia-Planella E; Menchén L; Nos P; Rodríguez-Lago I; Domènech E
Gastroenterol Hepatol; 2018; 41(7):458-471. PubMed ID: 30007787
[TBL] [Abstract][Full Text] [Related]
7. Budesonide: a useful tool in the maintenance treatment of Crohn's disease?
Schoon EJ
Neth J Med; 2007 Oct; 65(9):316-7. PubMed ID: 17954949
[No Abstract] [Full Text] [Related]
8. Maintenance treatment with budesonide 6 mg versus 9 mg once daily in patients with Crohn's disease in remission.
de Jong DJ; Bac DJ; Tan G; de Boer SY; Grabowsky IL; Jansen JB; Greinwald R; Naber TH
Neth J Med; 2007 Oct; 65(9):339-45. PubMed ID: 17954953
[TBL] [Abstract][Full Text] [Related]
9. Budesonide as maintenance treatment in Crohn's disease: a placebo-controlled trial.
Hanauer S; Sandborn WJ; Persson A; Persson T
Aliment Pharmacol Ther; 2005 Feb; 21(4):363-71. PubMed ID: 15709986
[TBL] [Abstract][Full Text] [Related]
10. [New therapeutic modalities in Crohn's disease].
Rachmilewitz D
Harefuah; 1999 Jun; 136(12):943-5. PubMed ID: 10955155
[No Abstract] [Full Text] [Related]
11. Rhabdomyolysis due to severe hypokaliemia in a Crohn's disease patient after budesonide treatment.
Mangone M; Spagnolo A; Capurso G; Marignani M; Panzuto F; Angeletti S; Ruggeri M; Menè P; Delle Fave G
Dig Liver Dis; 2007 Aug; 39(8):776-9. PubMed ID: 17049941
[TBL] [Abstract][Full Text] [Related]
12. Reversible dementia with parkinsonian features associated with budesonide use.
Prodan CI; Monnot M; Ross ED; Coleman AE
Neurology; 2006 Aug; 67(4):723. PubMed ID: 16924038
[No Abstract] [Full Text] [Related]
13. Treatment of Crohn's disease at the turn of the century.
Bickston SJ; Cominelli F
N Engl J Med; 1998 Aug; 339(6):401-2. PubMed ID: 9691110
[No Abstract] [Full Text] [Related]
14. Beclomethasone dipropionate for the treatment of mild-to-moderate Crohn's disease: an open-label, budesonide-controlled, randomized study.
Tursi A; Giorgetti GM; Brandimarte G; Elisei W; Aiello F
Med Sci Monit; 2006 Jun; 12(6):PI29-32. PubMed ID: 16733496
[TBL] [Abstract][Full Text] [Related]
15. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease.
Mantzaris GJ; Petraki K; Sfakianakis M; Archavlis E; Christidou A; Chadio-Iordanides H; Triadaphyllou G
Clin Gastroenterol Hepatol; 2003 Mar; 1(2):122-8. PubMed ID: 15017504
[TBL] [Abstract][Full Text] [Related]
16. Budesonide modified-release capsules.
Baker DE
Rev Gastroenterol Disord; 2001; 1(3):147-55. PubMed ID: 12120182
[TBL] [Abstract][Full Text] [Related]
17. Initial therapy for mild to moderate Crohn's disease: mesalamine or budesonide?
Feagan BG; Sandborn WJ
Rev Gastroenterol Disord; 2002; 2 Suppl 2():S9-15. PubMed ID: 12478239
[TBL] [Abstract][Full Text] [Related]
18. [Observation of the growth of asthmatic children treated with inhaled steroids].
Bourland RE
Salud Publica Mex; 2001; 43(3):179-80. PubMed ID: 11452690
[No Abstract] [Full Text] [Related]
19. [Budesonide: effective, with low side effects. On the road to new treatment methods in Crohn disease].
Internist (Berl); 1998 Sep; 39(9 Suppl Auf Dem We):1-8. PubMed ID: 9772715
[No Abstract] [Full Text] [Related]
20. Budesonide (Entocort EC) for Crohn's disease.
Med Lett Drugs Ther; 2002 Jan; 44(1122):6-8. PubMed ID: 11856950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
